Warning: Parameter 2 to flowplayer3_swftools_flashvars() expected to be a reference, value given in module_invoke() (line 476 of /var/www/pressflow/includes/module.inc).
FDA IS URGED TO PULL ORTHO EVRA   May 8, 2008

Ortho Evra is again under attack because of its increased risks of serious blood clots, pulmonary embolism, deep vein thrombosis and death among young women who use the product.

Reuters is reporting that Public Citizen's Helath Research Group has filed a petition with the FDA urging them to remove Johson & Johnson's Ortho Evra birth control patch from the market.  Continue reading ⇒

Important Update - Pre-Emption   February 22, 2008

On February 20, 2008 the United States Supreme Court in a decision written by Justice Scalia, Estate of Rigel v. Continue reading ⇒

Actavis Recalls Certain Fentanyl Patches in the US as Precaution   February 19, 2008

FOR IMMEDIATE RELEASE -- Morristown, NJ -- February 17, 2008 -- Actavis Inc., the United States manufacturing and marketing division of the international generic pharmaceutical company Actavis Group hf, today announced that 14 lots of Fentanyl transdermal system CII patches sold in the United States by Actavis' subsidiary Actavis South Atlantic LLC are being voluntarily r Continue reading ⇒

In: Tags:
FDA ADVISORY - FEBRUARY 15, 2008   February 16, 2008
Duragesic 25 mcg/hr (fentanyl transdermal system) CII Pain Patches
Audience: Pain management specialists, other healthcare professionals, patients [Posted 02/15/2008] PriCara and Sandoz Inc. announced a nationwide recall of all lots of 25 mcg/hr Duragesic Patches sold in the United States.
Continue reading ⇒
Asbestos - Help For Mesothelioma Victims   February 14, 2008

Our affiliated asbestos attorneys aggressively seek to protect the rights and obtain financial recoveries for the victims of Asbestos exposure particularly those suffering from mesothelioma. Mesothelioma is a rare lung cancer caused by exposure to asbestos. If you or your loved one has been diagnosed with mesothelioma it is more likely than not to have been caused by exposure to asbestos. Continue reading ⇒

In: Tags:
Plans To Boost Sales Despite Continued Safety Concerns Surrounding Avandia   February 12, 2008

The slumping sales of Avandia have seriously impacted the profitability of GlaxoSmithKline (GSK). Wall Street analysts have downgraded the stock amid rising concerns of impending litigation involving Avandia and Paxil and increased generic competition that will continue to erode GSK's market share. Continue reading ⇒

Chantix - FDA Concerned About Risk of Suicide   February 2, 2008

On February 1, 2008, the FDA issued a public health advisory regarding Chantix and announced new safety information and warnings to the labeling. The new labeling includes revisions to the WARNINGS and PRECAUTIONS sections of the prescribing information for Chantix regarding serious neuropsychiatric symptoms experienced in patients taking Chantix. Continue reading ⇒

In: Tags:
MDL court rejects certification of medical monitoring class   January 23, 2008

On January 3, 2008, the Hon. John F. Keenan welcomed in the new year with a memorandum and order denying class certification of three putative medical monitoring classes in the Fosamax product liability multidistrict litigation, In re Fosamax Products Liability Litigation, MDL No. 1789, 1:06-md-1789-JFK, pending in the United States District Court for the Southern District of New York. Continue reading ⇒

AVANDIA WARNING: FDA TO REQUIRE BLACK BOX WARNING OF INCREASED RISK OF HEART ATTACKS FOR AVANDIA USERS   November 15, 2007

On November 14, 2007 the FDA informed healthcare professionals of new information that was added to Avandia's black boxed warning. The FDA now requires that patients and physicians be warned of potential increased risk for heart attacks. Continue reading ⇒

AVANDIA MDL SET IN THE EASTERN DISTRICT OF PENNSYLVANIA   November 13, 2007

The Avandia multidistrict litigation docket has been created and assigned to U.S. Judge Cynthia M. Rufe of the Eastern District of Pennsylvania (In Re: Avandia Marketing, Sales Practices and Products Liability Litigation, MDL Docket No. 1871, JPMDL).  Continue reading ⇒

Lawsuits of Interest

Zocor/Vytorin
Zometa
Fill out this form for a free evaluation:
Please type your name.
Please type your email address.
Please select the cause of your injury.
Enter any information that you would lke us to know.